The meta-analyses for the 1-year survival among individuals with IDH -wt tumors and for the 2-year survival among all individuals with glioblastoma showed a trend toward increased mortality in individuals with oncogenic variants of TP53 without statistical significance.
← all excerpts
<i>TP53</i> oncogenic variants as prognostic factors in individuals with glioblastoma: a systematic review and meta-analysis.
1
—
—